Ligand to Acquire APEIRON Biologics AG for $100 Million
08 Jul 2024 //
BUSINESSWIRE
BeiGene and EUSA Pharma announce China NMPA approval of QARZIBA.
17 Aug 2021 //
BUSINESSWIRE
EUSA Pharma and BeiGene Announce Acceptance of a BLA for QARZIBA
09 Nov 2020 //
BUSINESSWIRE
United Therap`s Biological Dinutuximab Receives Approval In US
29 Sep 2020 //
FDA
United Therapeutics Announces Study of Unituxin® for Small Cell Lung Cancer
03 Feb 2020 //
PR NEWSWIRE
SMC endorses EUSA Pharma’s Qarziba
13 Nov 2018 //
PHARMA TIMES
Y-mAbs preps $92M IPO to push lead assets through regulatory filing
28 Aug 2018 //
FIERCE BIOTECH
EUSA Pharma: NICE approves QARZIBA (dinutuximab beta) for neuroblastoma
14 Jul 2018 //
BUSINESSWIRE